Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Diffuse Parenchymal Lung Disease
•
LAM
What is your approach to counseling and managing patients with LAM desiring pregnancy?
Related Questions
What is your approach to treatment in a patient with radiographic UIP but pathologic evidence of both fibrotic NSIP and UIP?
Do you routinely integrate telomere length testing into the evaluation of patients with ILD?
Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
What factors would encourage you to choose abatacept vs tocilizumab in a patient with RA-ILD with a UIP pattern of pulmonary fibrosis?
When do you consider systemic therapy for patients with progressive fibrosing mediastinitis?
What criteria do you use to decide when to perform a BAL in hypersensitivity pneumonitis?
What are your thoughts on using abatacept for RA-associated ILD in a patient undergoing treatment for CLL with zanubrutinib, and how would you assess the potential increased risk of infection in this context?
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
Would you consider using steroids in patients with respiratory failure caused by aspiration pneumonitis?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
